These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 22832429)

  • 21. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.
    Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I
    Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and drug induced side effects in early versus late antidepressant responders.
    Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
    J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression.
    Pettai K; Milani L; Tammiste A; Võsa U; Kolde R; Eller T; Nutt D; Metspalu A; Maron E
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1475-1483. PubMed ID: 27461515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chipping away at major depressive disorder.
    Rucker JJ; McGuffin P
    Genome Biol; 2014 Jul; 15(7):421. PubMed ID: 25315250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.
    Ju C; Fiori LM; Belzeaux R; Theroux JF; Chen GG; Aouabed Z; Blier P; Farzan F; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Milev R; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Uher R; Li Q; Foster JA; Kennedy SH; Turecki G
    Transl Psychiatry; 2019 Oct; 9(1):254. PubMed ID: 31594917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder.
    Wang Q; Dwivedi Y
    World J Biol Psychiatry; 2017 Dec; 18(8):592-603. PubMed ID: 27269743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism.
    Drevets WC; Bogers W; Raichle ME
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):527-44. PubMed ID: 12468016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
    Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
    Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.
    Eyre HA; Eskin A; Nelson SF; St Cyr NM; Siddarth P; Baune BT; Lavretsky H
    Int J Geriatr Psychiatry; 2016 May; 31(5):510-7. PubMed ID: 26471432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
    Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P
    Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
    McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
    Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment.
    Schmidt FM; Nowak C; Kratzsch J; Sander C; Hegerl U; Schönknecht P
    J Affect Disord; 2015 Jul; 180():207-13. PubMed ID: 25932975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
    Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
    BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U; Wade A; Andersen HF
    Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.